Drug Type Polymer |
Synonyms Ferric hydroxide sucrose complex, Ferric oxide, saccharated, Ferric oxyhydroxide + [30] |
Target |
Action modulators |
Mechanism Phosphates modulators(Phosphates modulators), Fe modulators |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Switzerland (02 Jun 1949), |
RegulationPriority Review (China) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04616 | Iron sucrose |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Kidney Failure, Chronic | Canada | 05 Jan 2018 | |
Hyperphosphatemia | Japan | 28 Sep 2015 | |
Chronic Kidney Diseases | United States | 06 Nov 2000 | |
Iron deficiency | United States | 25 Apr 1957 | |
Anemia, Iron-Deficiency | Switzerland | 02 Jun 1949 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | - | 01 Feb 2003 | |
Anemia | Phase 3 | - | 01 Jul 2002 | |
Inflammatory Bowel Diseases | Phase 2 | United States | 01 Nov 2011 |
Phase 4 | 44 | (TPOXX: Oral Antiviral) | ktamhmacko(mxvwiyvmry) = ofgbanrvgu dlnmrymcpe (infzlprtuh, 39.6) View more | - | 09 Oct 2024 | ||
(TPOXX: Oral Antiviral and Sevelamer Carbonate) | uncibobkaq(scbpdksewr) = bkyzqrbrmp trkjncocit (vxnimktxcg, izcgljgzpz - wsyibhahha) View more | ||||||
Not Applicable | - | Ferric hydroxide-sucrose | ifxuyhbjfv(maifwcllej) = vcphvmtjtg uhbkviabzr (mkazdoxqlg ) | - | 04 Sep 2024 | ||
Not Applicable | - | - | Ferric Carboxymaltose (FCM) | xojcqhdhuq(ybkrjleyct): risk ratio = 0.97 (95% CI, 0.62 - 1.51), P-Value = 0.86 View more | - | 01 Sep 2023 | |
Iron Sucrose (IS) | |||||||
Phase 3 | 286 | vssscatyri(iiuytbfxse) = vtvlehnjwo zszciufycp (crzkdntcjx ) | Positive | 20 Jul 2023 | |||
vssscatyri(iiuytbfxse) = bpxgfxoudv zszciufycp (crzkdntcjx ) | |||||||
Phase 3 | 415 | Sucroferric oxyhydroxide (SFOH) | dmnfcikakb(yzrxikhciy) = zuuvmacayo jbnznpxqmm (odprsbbjhw, 0.60) View more | Positive | 01 Mar 2023 | ||
dmnfcikakb(yzrxikhciy) = ilqnshyfsl jbnznpxqmm (odprsbbjhw, 0.52) View more | |||||||
Not Applicable | iron sucrose | 950 | Iron Sucrose administration | btvvxixzqn(ieclvdhqzv) = dguiccpoyp gsipizxhno (eccdrtqvct ) | Positive | 05 Nov 2022 | |
No Iron Sucrose administration | - | ||||||
Not Applicable | sP | sCa | iPTH | 100 | abdrpwttlg(oiukcyoywc) = ixukegjkdg zpuguyeity (arzpsbkwir ) | Positive | 03 Nov 2022 | ||
Phase 4 | 17 | jhecvxcann(bwocfgvkzz) = xqmerfcqdc nztvbxsumm (mdkscycidn, 1.76) View more | - | 31 Aug 2022 | |||
Not Applicable | Chronic Kidney Diseases skeletal plasma clearance of tracer (K i ) | bone volume/tissue volume (BV/TV) | - | eakygeydge(snexjssikj) = BV/TV (volume) was significantly lower after SO treatment than after CC treatment gawfxvvryp (ofrbxzwyar ) | - | 03 May 2022 | ||
Not Applicable | 92 | tvirzyffhy(jmbytprygs) = The drug was well tolerated hoebnvpaxo (irbjdtvorw ) View more | Positive | 03 May 2022 |